FDA Cosmetic Adverse Event Data Beg Question: Mandatory Reporting?
This article was originally published in The Tan Sheet
Executive Summary
Legislation to update cosmetics oversight would require companies to report serious adverse events, which could propel numbers upward while providing FDA with greater insight to the marketplace. According to FDA data, cosmetic-related AERs in 2015 more than tripled from 2009, with consumers doing most reporting.